Lung Cancer | Tumor

CURE’s lung cancer page is an extensive resource of cancer information featuring the latest lung cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on lung cancer.

Increased Importance: Rare Genomic Alterations in Lung Cancer

November 23rd 2020

As our understanding of lung cancer broadens, experts are now looking to rare genomic alterations that lead to aggressive lung cancer.

Patients With Lung Cancer Should Be Cautious, But Not Fearful of COVID-19

November 19th 2020

Patients with lung cancer should take all recommended precautions against COVID-19, but they must also keep up with their cancer care, doctors advise.

All Are Welcome: A Real-Life Lung Cancer 'Living Room'

November 18th 2020

Bonnie Addario, a 16-year lung cancer survivor, shares a message of hope and invites you to ‘The Living Room.’

How The Community Can Help Combat Access to Lung Cancer Screening, Care Issues

November 18th 2020

CURE® spoke with Dr. David Cooke, on behalf of the American Lung Association, on addressing racial disparities in lung cancer screening and care.

Racial and Other Disparities Persist Among Patients with Extensive-Stage Small Cell Lung Cancer

November 16th 2020

Among patients with extensive-stage small cell lung cancer, several groups were found to receive chemotherapy less often compared with White patients. They included Black, older and uninsured patients as well as those with nonprivate health insurance.

Health Care Costs Should Not Compromise Cancer Care

November 11th 2020

The cost of cancer care is often an insurmountable challenge for many patients, in particular patients with lung cancer. Many of whom will die because they cannot afford treatment. Health care costs must not compromise care.

Newly Diagnosed? Rely on ‘Research and Hope’, Says Doctor Turned Patient With Cancer

November 11th 2020

Doctor turned patient with cancer, Dr. Dan Tran, discusses how research and new medicine can help your hang onto hope during the cancer journey.

Doctor-Turned-Patient Focuses On What He Can Control After a Lung Cancer Diagnosis at Age 30

November 10th 2020

Dr. Dan Tran discusses his stage 4 lung cancer diagnosis at age 30, and how he has managed the shift from doctor to the patient with cancer.

Drug Targeting Offers Hope for Patients with Non-Small Cell Lung Cancer that Harbors Rare Mutations

October 30th 2020

Ultra-precise drug targeting brings new hope for patients with non-small cell lung cancer that harbors rare mutations.

CURE’s Clinical Trial Corner: October 2020

October 29th 2020

Here is a list of some recent trials that launched within the cancer space in October.

Bringing Together the Lung Cancer Community

October 22nd 2020

In this episode of the “CURE Talks Cancer” podcast, we looked back on CURE’s Lung Cancer Heroes event and recognized each winner that helps bring together the lung cancer community to raise awareness.

THE LIVING ROOM: A Lung Cancer Community of Courage

October 16th 2020

Bonnie Addario, our co-founder, board chair, survivor, and inspiration for thousands of patients here and around the world, shares the powerful stories of lung cancer patients and how they found ways to survive – and thrive -- in her book, The Living Room.

CURE®’s Inaugural Lung Cancer Heroes Program Honors Several Individuals Who Have Dedicated Their Lives and Careers to Improving Care for Patients

October 16th 2020

Two physicians, a nurse and a patient advocate were honored during CURE®’s first ever Lung Cancer Heroes program.

Dealing with the Isolation of Cancer Treatment

October 5th 2020

Larry Whipple had to travel 1,500 miles from his hometown for a second opinion after he was diagnosed with advanced lung cancer, but through the course of his treatment he had to remain in isolation to avoid further illness.

Experimental Treatment Shows Promise for Certain Cases of Advanced NSCLC

September 23rd 2020

There is no approved treatment that targets the KRAS p.G12C mutation that drives some cancers like non-small cell lung cancer. But a recent study shows how the experimental drug sotorasib sparked responses in some patients with advanced non-small cell lung cancer that harbored the mutation.

CURE Media Group Announces Winners of the Inaugural 2020 Lung Cancer Heroes™ Awards

September 22nd 2020

Four exceptional heroes will be honored along with the Lifetime Achievement award winner, who has provided a significant impact in the lung cancer community.

Adding Immunotherapy to Radiotherapy Increases Survival in Patients with Brain Metastases

September 16th 2020

The addition of immunotherapy to radiotherapy increased the overall survival of patients with cancer who developed brain metastases, according to new research.

Friday Frontline: Actress Dame Dianna Rigg Dies of Lung Cancer, Video of Health Insurance Dispute Between a Cancer Survivor and Senate Staffer Goes Viral, and More

September 11th 2020

From the passing of famed Game of Thrones actress Dame Dianna Rigg after a lung cancer diagnosis to the recording of a confrontational call between a three-time cancer survivor and her senator’s staffer, here’s what’s happening in the cancer headlines this week.

‘Trust, But Verify’: How a Cancer Survivor Became His Own Best Advocate

September 10th 2020

This week on the “CURE Talks Cancer” podcast, we spoke with Larry Whipple — a lung cancer survivor who became his own best advocate — about how his insistence on the best care led to results he could only dream of, and how other patients with cancer can take an active role in their own care, too.

Personalized Medicine, Genetic Testing Could Shape the Future of Non-Small Cell Lung Cancer

September 9th 2020

Dr. Nathan A. Pennell discusses the key genetic markers for treating patients with non-small cell lung cancer with targeted therapies.

FDA Approves Gavreto for Metastatic Non-Small Cell Lung Cancer Subset

September 5th 2020

The Food and Drug Administration approves Gavreto for treatment of patients with metastatic, RET fusion-positive non-small cell lung cancer.

Ensartinib Improves Progression-Free Survival in Patients with ALK-Positive NSCLC

August 27th 2020

The novel next-generation ALK tyrosine kinase inhibitor improved survival, compared with Xalkori, in patients with ALK-positive non-small cell lung cancer, potentially representing a new option in the first-line setting.

FDA Approves Comprehensive Multi-Tumor Liquid Biopsy Test FoundationOne Liquid CDx for Solid Tumors

August 27th 2020

The test was also approved as a companion diagnostic test to determine which select patients with metastatic castration-resistant prostate cancer could benefit from Rubraca, as well as for three frontline TKIs in patients with non-small cell lung cancer.

Generic Form of Pemetrexed Approved to Treat Non-Squamous Non-Small Cell Lung Cancer

August 26th 2020

The FDA has approved a generic form of the intravenous chemotherapy pemetrexed for use by itself in patients with locally advanced or metastatic non-squamous non-small cell lung cancer that has not progressed following four cycles of initial platinum-based chemotherapy.

Radiomic Analysis of CT Scans Can Predict Aggressiveness of Early Stage Lung Cancer

August 21st 2020

Specific measures of a tumor’s texture and intensity as they appear on CT images can help determine how much treatment patients with early stage lung cancer need, a study found.

Playing with a ‘Crappy’ Set of Cards Lung Cancer Dealt

August 20th 2020

In this episode of the “CURE Talks Cancer” podcast, we spoke with Dr. Dan Tran about his journey with stage 4 lung cancer and what advice he offers other survivors and patients with cancer.

FDA Grants Priority Review to New Fixed-Dose of Imfinzi in NSCLC and Bladder Cancer

August 18th 2020

If approved by the FDA, Imfinzi could be administered every four weeks at a fixed dose in patients with stage 3 NSCLC after they received chemoradiation, as well as in patients with previously treated bladder cancer.

FDA Grants Priority Review to Trilaciclib for Patients with Small Cell Lung Cancer

August 17th 2020

The Food and Drug Administration granted a priority review to the new drug application for trilaciclib for patients with small cell lung cancer.

More Quality-of-Life Research ‘Extremely Important’ for Patients with Cancer

August 17th 2020

“Therapeutic trials are very, very important because thanks to them, our patients are living longer,” said Dr. Narjust Duma. “But (physicians) also need to stop and ask how our patients are living.”

Lung Cancer

May 6th 2020

Understanding lung cancer.